# Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

> **NCT00493896** · PHASE3 · TERMINATED · sponsor: **Eastern Virginia Medical School** · enrollment: 27 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Fondaparinux
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT00493896
- **Lead sponsor:** Eastern Virginia Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2022-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493896, "Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00493896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*